NEW YORK—An executive vice president of biotechnology company Auxilium Pharmaceuticals Inc. exercised options for 90,750 shares of common stock, according to a Securities and Exchange Commission filing Friday.
In a Form 4 filed with the SEC, Jyrki Mattila reported exercising the options Wednesday for $4.50 to $5.36 apiece and then selling all the shares the same day for $30.45 apiece.
Insiders file Form 4s with the SEC to report transactions in their companies' shares. Open market purchases and sales must be reported within two business days of the transaction.
Auxilium Pharmaceuticals is based in Malvern, Penn.
© Copyright 2008 Associated Press. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
